This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Myers, K. R. Articles by Golding, B. Search for Related Content PubMed PubMed Citation Articles by Myers, K. R. Articles by Golding, B.

 Previous Article  |  Next Article 

Infect. Immun., Jan 1995, 168-174, Vol 63, No. 1
Copyright © 1995, American Society for Microbiology

Monophosphoryl lipid A behaves as a T-cell-independent type 1 carrier for hapten-specific antibody responses in mice

KR Myers, P Beining, M Betts, H Snippe, J Inman and B Golding
Ribi ImmunoChem Research, Inc., Hamilton, Montana 59840.

It is known that the lipopolysaccharide (LPS) of gram-negative bacteria, in addition to being a potent adjuvant, is an effective carrier for covalently associated haptens. However, the toxic nature of most forms of LPS precludes their use as adjuvants or carriers for human vaccines. 4'-Monophosphoryl lipid A (MLA), a derivative of LPS with attenuated toxicity, is currently being tested in humans as an immunological adjuvant. In this study, MLA was tested for its ability to function as a carrier for a small hapten, the trinitrophenyl group (TNP). MLA was first modified by addition of 6-aminocaproic acid to the 6' position of the disaccharide backbone (Cap-MLA). TNP was then attached to Cap-MLA via the free amino group, yielding TNP-Cap-MLA. Immunization of normal mice with TNP-Cap-MLA resulted in high-titer anti-TNP responses of immunoglobulin M and all immunoglobulin G subclasses. Furthermore MLA, like other T-cell-independent type 1 (TI- 1) carriers, induced responses in athymic and X-linked immunodeficient mice. In all cases, immunization with either MLA alone or TNP-Cap plus MLA failed to induce measurable anti-TNP antibodies of any isotype, indicating that covalent association of MLA and hapten was necessary for MLA's carrier activity to be manifested. These properties of MLA make it a potential candidate as a carrier for vaccine subunit components, such as small peptides, especially for situations in which T-cell help is impaired, as occurs following human immunodeficiency virus type 1 infection.

This article has been cited by other articles:

• Martin, M., Michalek, S. M., Katz, J. (2003). Role of Innate Immune Factors in the Adjuvant Activity of Monophosphoryl Lipid A. Infect. Immun. 71: 2498-2507 [Abstract] [Full Text]  
• Yang, Q.-B., Martin, M., Michalek, S. M., Katz, J. (2002). Mechanisms of Monophosphoryl Lipid A Augmentation of Host Responses to Recombinant HagB from Porphyromonas gingivalis. Infect. Immun. 70: 3557-3565 [Abstract] [Full Text]  
• Childers, N. K., Miller, K. L., Tong, G., Llarena, J. C., Greenway, T., Ulrich, J. T., Michalek, S. M. (2000). Adjuvant Activity of Monophosphoryl Lipid A for Nasal and Oral Immunization with Soluble or Liposome-Associated Antigen. Infect. Immun. 68: 5509-5516 [Abstract] [Full Text]  
• Xi, L., Jarrett, N. C., Hess, M. L., Kukreja, R. C. (1999). Essential Role of Inducible Nitric Oxide Synthase in Monophosphoryl Lipid A–Induced Late Cardioprotection : Evidence From Pharmacological Inhibition and Gene Knockout Mice. Circulation 99: 2157-2163 [Abstract] [Full Text]